Skip to main content
. Author manuscript; available in PMC: 2013 Dec 9.
Published in final edited form as: Am J Psychiatry. 2011 Aug 24;168(10):10.1176/appi.ajp.2011.10111577. doi: 10.1176/appi.ajp.2011.10111577

TABLE 2.

Interactions Among Selected FKBP5 Single-Nucleotide Polymorphisms (SNPs), Prebaseline Adverse Life Events, and the Risk of the First Occurrence of a Major Depressive Episode in 884 Young Community Subjects in a 10-Year Prospective Study

Additive Interaction Effect Between Prebaseline Adverse Life Event and Homozygosity for SNP Minor Allele on Incident Major Depressive Episode During Follow-Upb
Homozygous for Minor Allele Versus Heterozygous
Homozygous for Minor Allele Versus Homozygous for Major Allele
SNPa and Presence of Lifetime Adverse Event Preceding Baseline Risk Difference in Percentage Pointsc 95% CI p Risk Difference in Percentage Pointsc 95% CI p
rs3800373 (CC/AC/AA)
    Any adverse life event 13.0d 3.2 to 22.7 0.009 7.0 –7.6 to 21.6 0.35
    Any separation event 11.0d 0.0 to 22.0 0.05 3.7 –13.0 to 20.4 0.67
    Any trauma 15.3d,e,f 9.0 to 21.6 <0.001 15.2d,e,f 8.0 to 22.3 <0.001
    Any severe trauma 16.7d,e,f 12.0 to 21.4 <0.001 16.1d,e,f 10.1 to 22.1 <0.001
rs9296158 (AA/AG/GG)
    Any adverse life event 13.0d 3.7 to 22.4 0.006 6.4 –7.9 to 20.6 0.39
    Any separation event 12.2d 2.9 to 21.6 0.01 2.2 –14.4 to 18.7 0.80
    Any trauma 12.3d 3.5 to 21.2 0.006 14.0d,e,f 6.4 to 21.7 <0.001
    Any severe trauma 13.3d,e 5.6 to 21.0 <0.001 14.4d,e,f 7.3 to 21.4 <0.001
rs1360780 (TT/CT/CC)
    Any adverse life event 12.7d 3.1 to 22.4 0.009 6.1 –8.2 to 20.5 0.40
    Any separation event 11.6d 1.6 to 21.6 0.03 2.0 –14.6 to 18.6 0.82
    Any trauma 12.7d,e 4.1 to 21.2 0.003 14.0d,e,f 6.4 to 21.6 <0.001
    Any severe trauma 13.5d,e,f 5.9 to 21.0 <0.001 14.4d,e,f 7.5 to 21.3 <0.001
rs9470080 (TT/CT/CC)
    Any adverse life event 11.6d 1.3 to 21.8 0.03 2.4 –13.6 to 18.3 0.78
    Any separation event 9.4 –2.3 to 21.2 0.12 –3.4 –23.3 to 16.5 0.74
    Any trauma 13.1d,e,f 5.2 to 21.0 0.001 13.2d,e,f 5.3 to 21.1 0.001
    Any severe trauma 13.6d,e,f 6.7 to 20.8 <0.001 13.3d,e,f 5.7 to 20.9 <0.001
rs4713916 (AA/AG/GG)
    Any adverse life event 18.0d,e,f 10.2 to 25.7 <0.001 15.2d 3.3 to 27.1 0.02
    Any separation event 12.8d 3.0 to 22.6 0.01 5.6 –10.4 to 21.6 0.50
    Any trauma 15.9d,e,f 10.6 to 21.2 <0.001 16.6d,e,f 11.3 to 21.9 <0.001
    Any severe trauma 16.0d,e,f 11.5 to 20.6 <0.001 16.3d,e,f 11.5 to 21.2 <0.001
a

Minor allele is listed first, i.e., for rs3800373 the minor allele is C; for rs9296158 the minor allele is A; for rs1360780 the minor allele is T; for rs9470080 the minor allele is T; and for rs4713916 the minor allele is A.

b

A total of 159 individuals first met the DSM-IV criteria for a major depressive episode during follow-up. The reference group comprised the subjects without an incident major depressive episode during follow-up.

c

The amount by which the sum of the independent effects of an adverse life event (in the absence of the risk genotype, i.e., homozygosity for the minor allele) and the risk genotype (in the absence of adverse life events) is exceeded by the joint effect of both factors, i.e., an adverse life event in the presence of the risk genotype.

d

Significant risk difference (p<0.05) when controlled for age and gender.

e

Significant risk difference (p<0.05) when controlled for age and gender and after Bonferroni correction for multiple testing (two independent event conditions, five SNPs).

f

Significant risk difference (p<0.05) when controlled for age, gender, and baseline anxiety and substance use disorders and after Bonferroni correction for multiple testing (two independent event conditions, five SNPs).